12 unknown. 12 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Unknown 12 |
| Phase 2 | 3 | Unknown 3 |
Follow Acute Ischemic Stroke: new trials by email Literature Review of Acute Ischemic Stroke trials Research Report on Acute Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GD-11 for Injection in the Treatment of Acute Ischemic Stroke GD-11 for injection test group, Placebo control group - Acute Ischemic Stroke | Phase 3 | Unknown | Beijing Tiantan Hospital | 980 | 2024-02-29 | 2024-03-15 |
| Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy Intra-Arterial TNK and Albumin, Intra-Arterial TNK, Intra-Arterial Albumin - Acute Ischemic Stroke | Phase 3 | Unknown | Tianjin Huanhu Hospital | 80 | 2023-09-07 | 2023-11-02 |
| Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L) Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA) - Acute Ischemic Stroke | Phase 3 | Unknown | Ji Xunming,MD,PhD | 1230 | 2023-08-17 | 2024-03-28 |
| Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） Alteplase, Tenecteplase - Acute Ischemic Stroke | Phase 3 | Unknown | Beijing Tiantan Hospital | 1630 | 2022-10-26 | 2023-02-27 |
| Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy Tenecteplase - Acute Ischemic Stroke | Phase 3 | Unknown | Hospital Universitari Vall d'Hebron Research Institute | 500 | 2022-05-27 | 2022-11-25 |
| Citicoline in Ischemic Stroke Citicoline 500 MG - Acute Ischemic Stroke | Phase 3 | Unknown | Ain Shams University | 200 | 2021-07-22 | 2022-02-17 |
| Head-of-Bed Positioning in Large Artery Acute Ischemic Stroke Allocating head-of-bed position - Acute Ischemic Stroke | Phase 3 | Unknown | National University of Singapore | 182 | 2020-02-11 | 2023-11-15 |
| Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH) Eptifibatide Injection - Acute Ischemic Stroke | Phase 3 | Unknown | Ministry of Science and Technology of the People´s Republic of China | 220 | 2019-04-06 | 2019-06-18 |
| Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. AngongNiuhuang pill, Placebo of AngongNiuhuang pill, Standard treatment - Acute Ischemic Stroke | Phase 3 | Unknown | Peking Union Medical College Hospital | 100 | 2018-12-01 | 2018-11-07 |
| BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Mobile Stroke Unit Management - Acute Ischemic Stroke | Phase 2 / Phase 3 | Unknown | Memorial Hermann Health System | 1038 | 2014-08-01 | 2023-03-17 |
| Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke XSCR capsule (Composed of Traditional Chinese Medicine Huangqi, Chuanxiong, Chishao, Danggui, Dilong, Taoren, Honghua.), Placebo - Acute Ischemic Stroke | Phase 2 / Phase 3 | Unknown | Fudan University | 130 | 2008-09-01 | 2010-05-28 |
| Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke Angongniuhuang Pill, placebo - Stroke, Acute Ischemic Stroke | Phase 2 / Phase 3 | Unknown | Fudan University | 60 | 2010-05-28 |
Ischemic Stroke (12) · Stroke (3)
Brain Diseases (12) · Cardiovascular Diseases (12) · Central Nervous System Diseases (12) · Cerebrovascular Disorders (12) · Nervous System Diseases (12) · Vascular Diseases (12) · Stroke (9)
Tenecteplase (2) · Albumins (1) · Cytidine Diphosphate Choline (1) · Eptifibatide (1) · Honghua extract, Carthamus tinctorius (1) · TNK-tissue plasminogen activator (1) · Tissue Plasminogen Activator (1) · salicylhydroxamic acid (1)
Beijing Tiantan Hospital (2) · Fudan University (2) · Ain Shams University (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Ji Xunming,MD,PhD (1) · Memorial Hermann Health System (1) · Ministry of Science and Technology of the People´s Republic of China (1) · National University of Singapore (1) · Peking Union Medical College Hospital (1) · Tianjin Huanhu Hospital (1)
China (8) · Egypt (1) · Singapore (1) · Spain (1) · United States (1)
Shuya Li (2) · Bin Peng, MD (1) · James C Grotta, MD (1)
PMID 11315017, PMID 11673584, PMID 1884569, PMID 20110753, PMID 22105690, PMID 28082671, PMID 28612680, PMID 29720439, PMID 32295510, PMID 33449944, PMID 34496173, PMID 35105182, PMID 41608799